106362-33-8 Usage
General Description
"(D-ALA1)-PEPTIDE T" is a synthetic peptide that has been scientifically designed to mimic the structure and function of natural peptide hormones. It is comprised of D-alanine, an amino acid, and peptide T, a short-chain peptide. Peptide T has been shown to have potential therapeutic applications in the treatment of various diseases, including HIV/AIDS, and it is believed to modulate the immune response. Research has also suggested that peptide T has neuroprotective properties and may be useful in the treatment of neurodegenerative diseases. Additionally, it has been studied for its potential to enhance cognitive function and memory. "(D-ALA1)-PEPTIDE T" represents a promising avenue for the development of novel therapeutic interventions.
Check Digit Verification of cas no
The CAS Registry Mumber 106362-33-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,6,3,6 and 2 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 106362-33:
(8*1)+(7*0)+(6*6)+(5*3)+(4*6)+(3*2)+(2*3)+(1*3)=98
98 % 10 = 8
So 106362-33-8 is a valid CAS Registry Number.
InChI:InChI=1/C35H55N9O16/c1-13(36)28(52)40-22(12-45)31(55)41-25(15(3)47)33(57)43-26(16(4)48)34(58)42-24(14(2)46)32(56)39-21(11-23(37)51)29(53)38-20(10-18-6-8-19(50)9-7-18)30(54)44-27(17(5)49)35(59)60/h6-9,13-17,20-22,24-27,45-50H,10-12,36H2,1-5H3,(H2,37,51)(H,38,53)(H,39,56)(H,40,52)(H,41,55)(H,42,58)(H,43,57)(H,44,54)(H,59,60)
106362-33-8Relevant articles and documents
Treatment or prevention of Crohn's disease and/or ulcerative colitis
-
, (2008/06/13)
The present invention provides a method for the treatment or prevention of Crohn's disease and/or ulcerative colitis. The method involves the administration of Peptide T or its derivatives or analogues. Preferred compounds used in the method include: 1. D--Ala--Ser--Thr--Thr--Thr--Asn--Tyr--Thr--NH2 2. Ala--Ser--Thr--Thr--Thr--Asn--Tyr--Thr 3. D--Ala--Ser--Thr--Thr--Thr--Ans--Tyr--Thr 4. D--Ala--Ala--Ser--Ser--Ser--Asn--Tyr--Met 5. Thr--Asp--Asn--Tyr--Thr 6. Thr--Thr--Ser--Tyr--Thr 7. Thr--Thr--Asn--Tyr--Thr 8. D--Thr--Thr--Tyr--D--Thr 9. D--Ala--Ser--D--Thr--Thr--D--Thr--Asn--Tyr--D--Thr--NH2 10. D--Ser--Ser--D--Thr--Thr--D--Thr--Thr--Tyr--D--Thr--NH2
-
Barlos, Kleomenis,Gatos, Dimitrios,Koutsogianni, Sophia,Schaefer, Wolfram,Stavropoulos, George,Wenging, Yao
, p. 471 - 474 (2007/10/02)
The preparation of the N-Fmoc-O-Trt derivatives of serine, threonine and tyrosine is described. Their usefulness in peptide synthesis has been determined in the successful solid phase preparation of the partially protected ACTH (fragment 1-10) and peptide
